• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Alessandro Buda, Roldano Fossati, +12 authors Costantino Mangioni
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2005 (First Publication: 20 June 2005)
  • PURPOSE Neoadjuvant chemotherapy may represent an alternative to irradiation in locally advanced squamous cell cervical cancer. Aims of this study were to compare a three-drug (paclitaxel,Expand
  • Andrea Lissoni, Natália B. Colombo, +15 authors Eliana Rulli
  • Medicine
  • Annals of oncology : official journal of the…
  • 2009 (First Publication: 19 January 2009)
  • BACKGROUND The efficacy and tolerability of the regimen containing paclitaxel and cisplatin (TP) in the neo-adjuvant treatment of locally advanced squamous cell cervical cancer are unknown. The TIPExpand
  • Gerardo Zanetta, S Rota, Andrea Lissoni, A Meni, Giuseppe Brancatelli, Alessandro Buda
  • Medicine
  • Gynecologic oncology
  • 2001 (First Publication: 1 April 2001)
  • BACKGROUND Borderline ovarian tumors often affect women of childbearing age and the prognosis is outstanding. Given the young age of several patients and the good prognosis, fertility-sparing surgeryExpand
  • Sergio Marchini, Duccio Cavalieri, +15 authors Maurizio D'Incalci
  • Medicine
  • The Lancet. Oncology
  • 2011 (First Publication: 1 March 2011)
  • BACKGROUND International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer (EOC) has a significantly better prognosis than stage III/IV EOC, with about 80% of patientsExpand
  • Mauro Signorelli, Luca Guerra, +5 authors C. Messa
  • Medicine
  • Gynecologic oncology
  • 2009 (First Publication: 1 November 2009)
  • BACKGROUND High risk clinical stage I endometrial cancer (grade 2 and deep myometrial invasion, grade 3 and serous and clear-cell carcinoma) had 10-35% of nodal involvement. Surgical staging isExpand